Home › Compare › NEVPF vs STAG

NEVPF vs STAG: Dividend Comparison 2026

NEVPF yields 7142.86% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEVPF wins by $2020155342665731.25M in total portfolio value
10 years
NEVPF
NEVPF
● Live price
7142.86%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2020155342665731.25M
Annual income
$1,966,011,161,323,515,200,000.00
Full NEVPF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.06
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.70
Full STAG calculator →

Portfolio growth — NEVPF vs STAG

📍 NEVPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEVPFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEVPF + STAG cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NEVPF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEVPF
Annual income on $10K today (after 15% tax)
$607,142.86/yr
After 10yr DRIP, annual income (after tax)
$1,671,109,487,124,987,800,000.00/yr
STAG
Annual income on $10K today (after 15% tax)
$292.69/yr
After 10yr DRIP, annual income (after tax)
$393.29/yr
At 15% tax rate, NEVPF beats the other by $1,671,109,487,124,987,800,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEVPF + STAG for your $10,000?

NEVPF: 50%STAG: 50%
100% STAG50/50100% NEVPF
Portfolio after 10yr
$1010077671332865.63M
Annual income
$983,005,580,661,757,600,000.00/yr
Blended yield
97.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

NEVPF
No analyst data
Altman Z
-0.7
Piotroski
2/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.8% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEVPF buys
0
STAG buys
0
No recent congressional trades found for NEVPF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEVPFSTAG
Forward yield7142.86% ✓3.44%
Annual dividend / share$2.00 ✓$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3% ✓
Portfolio after 10y$2020155342665731.25M ✓$18.3K
Annual income after 10y$1,966,011,161,323,515,200,000.00 ✓$462.70
Total dividends collected$2016528271361529.00M ✓$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: NEVPF vs STAG ($10,000, DRIP)

YearNEVPF PortfolioNEVPF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$724,986$714,285.71$10,665$345.38+$714.3K → NEVPF
2$49,172,645$48,396,910.17$11,365$358.01+$49.16M → NEVPF
3$3,120,421,331$3,067,806,600.72$12,099$370.76+$3120.41M → NEVPF
4$185,281,229,916$181,942,379,091.82$12,870$383.63+$185281.22M → NEVPF
5$10,294,691,143,508$10,096,440,227,497.77$13,678$396.60+$10294691.13M → NEVPF
6$535,299,070,050,255$524,283,750,526,701.75$14,526$409.67+$535299070.04M → NEVPF
7$26,050,796,629,539,330$25,478,026,624,585,550.00$15,413$422.82+$26050796629.52M → NEVPF
8$1,186,669,129,317,434,600$1,158,794,776,923,827,700.00$16,343$436.05+$1186669129317.42M → NEVPF
9$50,602,038,637,584,920,000$49,332,302,669,215,270,000.00$17,315$449.35+$50602038637584.90M → NEVPF
10$2,020,155,342,665,731,300,000$1,966,011,161,323,515,200,000.00$18,332$462.70+$2020155342665731.25M → NEVPF

NEVPF vs STAG: Complete Analysis 2026

NEVPF — Stock

Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Full NEVPF Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this NEVPF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEVPF vs SCHDNEVPF vs JEPINEVPF vs ONEVPF vs KONEVPF vs MAINNEVPF vs PLDNEVPF vs EQRNEVPF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.